Outset Medical, Inc. financial data

Symbol
OM on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3052 Orchard Drive, San Jose, CA
State of incorporation
Delaware
Former names
Home Dialysis Plus, Ltd. (to 2/25/2011)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 591 % -13.6%
Quick Ratio 106 % +3.88%
Debt-to-equity 194 % +232%
Return On Equity -146 % -97.9%
Return On Assets -49.7 % -6.68%
Operating Margin -129 % +0.42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.1M shares +4.62%
Common Stock, Shares, Outstanding 52.1M shares +4.95%
Entity Public Float 1.1B USD +55.1%
Common Stock, Value, Issued 52K USD +4%
Weighted Average Number of Shares Outstanding, Basic 51.9K shares +5.98%
Weighted Average Number of Shares Outstanding, Diluted 51.9K shares +5.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 116M USD -9.94%
Research and Development Expense 51M USD -4.18%
Selling and Marketing Expense 86.1M USD -9.59%
General and Administrative Expense 46.3M USD +7.39%
Operating Income (Loss) -150M USD +10.3%
Nonoperating Income (Expense) 10.4M USD +29.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -159M USD +6.58%
Income Tax Expense (Benefit) 511K USD +24.9%
Net Income (Loss) Attributable to Parent -159M USD +6.5%
Earnings Per Share, Basic -3.12 USD/shares +10.3%
Earnings Per Share, Diluted -3.12 USD/shares +10.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.9M USD +4.04%
Cash, Cash Equivalents, and Short-term Investments 194M USD -14.7%
Accounts Receivable, after Allowance for Credit Loss, Current 34.1M USD -7.54%
Inventory, Net 61.6M USD +38.4%
Assets, Current 295M USD -4.61%
Property, Plant and Equipment, Net 10.9M USD -25.2%
Operating Lease, Right-of-Use Asset 4.68M USD -22.6%
Other Assets, Noncurrent 520K USD -53.9%
Assets 315M USD -5.95%
Accounts Payable, Current 5.26M USD +137%
Contract with Customer, Liability, Current 13.1M USD +20.8%
Liabilities, Current 43.4M USD -11%
Contract with Customer, Liability, Noncurrent 130K USD +46.1%
Operating Lease, Liability, Noncurrent 3.62M USD -31.9%
Liabilities 246M USD +62.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -302K USD +23.2%
Retained Earnings (Accumulated Deficit) -1.04B USD -18.2%
Stockholders' Equity Attributable to Parent 68.6M USD -62.5%
Liabilities and Equity 315M USD -5.95%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -45.9M USD -2.58%
Net Cash Provided by (Used in) Financing Activities 68.6M USD +1200%
Net Cash Provided by (Used in) Investing Activities -59M USD -2333%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 52.1M shares +4.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -36.3M USD +1.37%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.2M USD +3.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.92M USD +98.6%
Deferred Tax Assets, Valuation Allowance 222M USD +20.5%
Deferred Tax Assets, Gross 223M USD +20.2%
Operating Lease, Liability 6.08M USD -11.9%
Payments to Acquire Property, Plant, and Equipment 354K USD -56.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -159M USD +6.24%
Lessee, Operating Lease, Liability, to be Paid 7.01M USD -15.1%
Property, Plant and Equipment, Gross 29.6M USD +11.1%
Operating Lease, Liability, Current 1.69M USD +14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.11M USD +10.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.05M USD +10.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 934K USD -31.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.95M USD -0.86%
Deferred Tax Assets, Operating Loss Carryforwards 161M USD +22.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.78M USD +24.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.46M USD +5.49%
Deferred Tax Assets, Net of Valuation Allowance 1.34M USD -11.8%
Share-based Payment Arrangement, Expense 38M USD +13.7%
Interest Expense 18.6M USD +114%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%